Drugs / Mangaciclanol
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07472491 Comparator | Apr 2026 → Nov 2027 expected | — | GE Healthcare | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mangaciclanol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07472491 ↗ |
| Known as | GEH200486 Injection | “Single intravenous (IV) administration of Mangaciclanol (GEH200486 Injection, 0.5 mmol/mL) followed by a 20mL saline flush” NCT07472491 ↗ |
| Modality | Small molecule | — CHEMBL6068139 ↗ |
| Route | Intravenous | “Single intravenous (IV) administration of Mangaciclanol (GEH200486 Injection, 0.5 mmol/mL)” NCT07472491 ↗ |